Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?
Read More Pharma Industry News Aurobindo Pharma’s subsidiary Eugia Pharma gets FDA approval for Icatibant Injection In a pivotal move bolstering its footprint in the global pharmaceutical landscape, Aurobindo Pharma Limited’s subsidiary, Eugia Pharma… byPallavi MadhirajuAugust 16, 2023